Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-26

FDA Approved: SORAFENIB — Supplemental Application (Dr.Reddys Laboratories Inc)

View source ↗

Summary

FDA approved a supplemental application for sorafenib submitted by Dr. Reddy's Laboratories Inc. This action provides supplemental approval for this generic can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sorafenib (Sorafenib)

Snippet

SUPPL AP for SORAFENIB (SORAFENIB)